Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_assertion type Assertion NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_head.
- NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_assertion description "[To conclude, use of associated MMP-2 promoter genotype as a DNA marker might make it possible to distinguish between the patients with parapsoriasis and those with CTCL stage Ia, which could substantially improve possibilities of clinical diagnostics, therapy design, and prognosis of this serious condition in the early stages.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_provenance.
- NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_assertion evidence source_evidence_literature NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_provenance.
- NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_assertion SIO_000772 20625418 NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_provenance.
- NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_assertion wasDerivedFrom befree-2016 NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_provenance.
- NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_assertion wasGeneratedBy ECO_0000203 NP825493.RAwNxzpjKuyc3IkGSI8I7H-FEZ3QE2_wozRVytHDegTmI130_provenance.